Zobrazeno 1 - 10
of 249
pro vyhledávání: '"Françoise Rédini"'
Autor:
Maryne Dupuy, François Lamoureux, Mathilde Mullard, Anaïs Postec, Laura Regnier, Marc Baud’huin, Steven Georges, Bénédicte Brounais-Le Royer, Benjamin Ory, Françoise Rédini, Franck Verrecchia
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
In Europe, with an incidence of 7.5 cases per million, Ewing sarcoma (ES) is the second most common primary malignant bone tumor in children, adolescents and young adults, after osteosarcoma. Since the 1980s, conventional treatment has been based on
Externí odkaz:
https://doaj.org/article/96f03fca6f38466183cb1831951cf9a6
Autor:
Clément Veys, Flavie Boulouard, Abderrahim Benmoussa, Manon Jammes, Emilie Brotin, Françoise Rédini, Laurent Poulain, Nicolas Gruchy, Christophe Denoyelle, Florence Legendre, Philippe Galera
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Chondrosarcomas and osteosarcomas are malignant bone tumors with a poor prognosis when unresectable or metastasized. Moreover, radiotherapy and chemotherapy could be ineffective. MiRNAs represent an alternative therapeutic approach. Based on high-thr
Externí odkaz:
https://doaj.org/article/ca6a80213c7749da80be7ec384cce913
Autor:
Hélios Bertin, Sophie Peries, Jérôme Amiaud, Nathalie Van Acker, Bastien Perrot, Corinne Bouvier, Sébastien Aubert, Béatrice Marie, Frédérique Larousserie, Gonzague De Pinieux, Vincent Crenn, Françoise Rédini, Anne Gomez-Brouchet
Publikováno v:
Cancers, Vol 15, Iss 4, p 1004 (2023)
Background—The purpose of this study was to investigate the bone resorption, as well as the vascular and immune microenvironment, of jaw osteosarcomas (JO) and to correlate these features with patient clinical outcomes. Methods—We studied 50 JO b
Externí odkaz:
https://doaj.org/article/8f4ad314a7ab45f69cc5badfb735de1c
Autor:
Rémy Nicolle, Mira Ayadi, Anne Gomez-Brouchet, Lucile Armenoult, Guillaume Banneau, Nabila Elarouci, Matthias Tallegas, Anne-Valérie Decouvelaere, Sébastien Aubert, Françoise Rédini, Béatrice Marie, Corinne Labit-Bouvier, Nicolas Reina, Marie Karanian, Louis-Romée le Nail, Philippe Anract, François Gouin, Frédérique Larousserie, Aurélien de Reyniès, Gonzague de Pinieux
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
Chondrosarcomas are heterogenous tumours of the bone cartilage and have highly variable prognoses. Here, the authors perform a multi-omics analysis, revealing molecular features that can stratify clinical outcomes.
Externí odkaz:
https://doaj.org/article/9a7f2546f61d40c9b55be3f258fbc8df
Autor:
Régis Brion, Malika Gantier, Kevin Biteau, Julien Taurelle, Bénédicte Brounais-Le Royer, Franck Verrecchia, Françoise Rédini, Romain Guiho
Publikováno v:
Cancers, Vol 14, Iss 22, p 5627 (2022)
Despite advances in clinical management, osteosarcoma and Ewing sarcoma, the two most frequent malignant primary bone tumors at pediatric age, still have a poor prognosis for high-risk patients (i.e., relapsed or metastatic disease). Triggering a TRA
Externí odkaz:
https://doaj.org/article/f51c00964b814462afe87b5696a12fec
Autor:
Hélios Bertin, Romain Guilho, Régis Brion, Jérôme Amiaud, Séverine Battaglia, Anne Moreau, Anne Brouchet-Gomez, Julie Longis, Benoit Piot, Dominique Heymann, Pierre Corre, Françoise Rédini
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-8 (2019)
Abstract Background Osteosarcoma (OS) is the most common cancer of bone. Jaw osteosarcoma (JOS) is rare and it differs from other OS in terms of the time of occurrence (two decades later) and better survival. The aim of our work was to develop and ch
Externí odkaz:
https://doaj.org/article/d707e1ee54264011bee77fc5923a1c59
Autor:
Clément Veys, Manon Jammes, Françoise Rédini, Laurent Poulain, Christophe Denoyelle, Florence Legendre, Philippe Galera
Publikováno v:
Pharmaceuticals, Vol 15, Iss 3, p 362 (2022)
Osteosarcomas are the most common type of malignant bone tumor. These tumors are characterized by the synthesis of an osteoid matrix. Current treatments are based on surgery and combination chemotherapy. However, for metastatic or recurrent tumors, c
Externí odkaz:
https://doaj.org/article/d1d827e8820942d1898f94ac37aced44
Autor:
Aurélie Moniot, Julien Braux, Christine Guillaume, Ingrid Allart-Simon, Sandra Audonnet, Sarah Renault, Françoise Rédini, Janos Sapi, Sophie C. Gangloff, Stéphane Gérard, Frédéric Velard
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100682- (2020)
Externí odkaz:
https://doaj.org/article/78904c357ce042e0a092282fe45966e0
Autor:
Valérie Trichet, Louis-Romée Le Nail, Régis Brion, Françoise Rédini, François Vallette, Olivier Hérault, Christophe Olivier
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100421- (2020)
Externí odkaz:
https://doaj.org/article/865bd02b968c473bacfe4613e5032477
Autor:
Régis Brion, Laura Regnier, Mathilde Mullard, Jérome Amiaud, Françoise Rédini, Franck Verrecchia
Publikováno v:
Cells, Vol 10, Iss 12, p 3542 (2021)
Tumorigenesis is a long-term and multistage process that often leads to the formation of metastases. During this pathological course, two major events appear to be crucial: primary tumour growth and metastatic expansion. In this context, despite rese
Externí odkaz:
https://doaj.org/article/1c61661d1cca42bface97953110f855c